More than 100,000 people are enrolled in M.D. programs for the 2025-2026 academic year, according to data released yesterday by the Association of American Medical Colleges. It’s the first time total ...

In this morning's Pharmalittle roundup, we're reading about FDA scrutiny of RSV therapies, an AI tool for clinical trials, ...

In a closely watched case, the U.S. solicitor general has urged the Supreme Court to review a controversy over so-called ...

In today's D.C. Diagnosis newsletter, the Biosecure Act advances, but extra ACA subsidies are still up in the air.

Today we discuss why comparing U.S. vaccine policy to Europe’s is a red herring, why the revolving door at the FDA between ...

ASH's 2025 meeting ended with strong multiple myeloma data from J&J, a new treatment for a rare disorder, and strains on a ...

Radiology was an early adopter of AI technology but as researchers and startups forge ahead lean with a new wave of the ...

Care for patients with dementia has changed radically since Jason Karlawish started working in the field in the late ’90s, he says on STAT’s “First Opinion Podcast.” ...

Kuppalli is an infectious diseases physician in Dallas. I have spent my career caring for people facing some of the world’s most dangerous infectious diseases — Ebola, mpox, Covid-19. I have worked in ...

The FDA drug center’s new acting director Tracy Beth Høeg fits a pattern of risky, internal contradictions among agency ...

The chaos created by the freezing and termination of billions of dollars of research grants has left trans academics ...

Dispersing federal research funding, largely concentrated at private universities on the coasts, to the rest of the country ...